U
QSAM Biosciences, Inc. A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 2.78M 3.34M 3.51M 3.78M 4.44M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 3.94M 4.68M 4.73M 4.76M 5.46M
Operating Income -3.94M -4.68M -4.73M -4.76M -5.46M
Income Before Tax -4.39M -5.09M -5.15M -5.20M -5.48M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -4.39 -5.09 -5.15 -5.20 -5.48
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -4.39M -5.09M -5.15M -5.20M -5.48M
EBIT -3.94M -4.68M -4.73M -4.76M -5.46M
EBITDA -- -- -- -- --
EPS Basic -- -- -- -- --
Normalized Basic EPS -- -- -- -- --
EPS Diluted -- -- -- -- --
Normalized Diluted EPS -- -- -- -- --
Average Basic Shares Outstanding -- -- -- -- --
Average Diluted Shares Outstanding -- -- -- -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings